Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1

Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1

US Patent 9498467 · Granted Nov 22, 2016

Estimated economic value: $196,705,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosing regimen for the treatment of PI3K related disorders2025
Combination therapy for treatment of hematological diseases2022
Combination therapy for the treatment of acute leukemia and myelodysplastic synd2010
Multi-unit ribozyme inhibition of oncogene gene expression1997